Public Law 110-85
E651087
Public Law 110-85 is a 2007 U.S. federal statute that significantly expanded the Food and Drug Administration’s authority over drug and medical device safety, post-market surveillance, and user fees.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Public Law 110-85 canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T7168830 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Public Law 110-85 Context triple: [Food and Drug Administration Amendments Act of 2007, publicLawNumber, Public Law 110-85]
-
A.
Public Law 110-55
Public Law 110-55 is the official designation of the Protect America Act of 2007, a U.S. federal law that temporarily expanded government surveillance authorities in the context of foreign intelligence and counterterrorism.
-
B.
Public Law 110-175
Public Law 110-175 is a 2007 United States federal statute that significantly amended and strengthened the Freedom of Information Act to improve government transparency and public access to records.
-
C.
Public Law 110-181
Public Law 110-181 is a 2008 U.S. defense authorization statute that, among many provisions, governs and directs programs such as the Assembled Chemical Weapons Alternatives for the safe destruction of chemical weapons stockpiles.
-
D.
Public Law 107-110
Public Law 107-110 is the formal designation of the No Child Left Behind Act, a major U.S. federal education reform law enacted in 2002 to increase accountability in public schools.
-
E.
Public Law 110-325
Public Law 110-325 is the U.S. federal statute enacted in 2008 that broadened and clarified the protections of the Americans with Disabilities Act by expanding the definition of disability and limiting judicial restrictions on coverage.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Public Law 110-85 Target entity description: Public Law 110-85 is a 2007 U.S. federal statute that significantly expanded the Food and Drug Administration’s authority over drug and medical device safety, post-market surveillance, and user fees.
-
A.
Public Law 110-55
Public Law 110-55 is the official designation of the Protect America Act of 2007, a U.S. federal law that temporarily expanded government surveillance authorities in the context of foreign intelligence and counterterrorism.
-
B.
Public Law 110-175
Public Law 110-175 is a 2007 United States federal statute that significantly amended and strengthened the Freedom of Information Act to improve government transparency and public access to records.
-
C.
Public Law 110-181
Public Law 110-181 is a 2008 U.S. defense authorization statute that, among many provisions, governs and directs programs such as the Assembled Chemical Weapons Alternatives for the safe destruction of chemical weapons stockpiles.
-
D.
Public Law 107-110
Public Law 107-110 is the formal designation of the No Child Left Behind Act, a major U.S. federal education reform law enacted in 2002 to increase accountability in public schools.
-
E.
Public Law 110-325
Public Law 110-325 is the U.S. federal statute enacted in 2008 that broadened and clarified the protections of the Americans with Disabilities Act by expanding the definition of disability and limiting judicial restrictions on coverage.
- F. None of above. chosen
Statements (46)
| Predicate | Object |
|---|---|
| instanceOf |
Act of Congress
ⓘ
United States federal statute ⓘ |
| aimsTo |
enhance medical device safety oversight
ⓘ
improve drug safety monitoring ⓘ increase transparency of clinical trials ⓘ |
| amends |
Federal Food, Drug, and Cosmetic Act
NERFINISHED
ⓘ
Public Health Service Act NERFINISHED ⓘ |
| authorizes | Risk Evaluation and Mitigation Strategies NERFINISHED ⓘ |
| authorizesAppropriationsFor | Food and Drug Administration NERFINISHED ⓘ |
| concerns |
medical device user fees
ⓘ
prescription drug user fees ⓘ |
| creates | Pediatric Medical Device Safety and Improvement Act provisions NERFINISHED ⓘ |
| establishes | Food and Drug Administration Amendments Act Risk Evaluation and Mitigation Strategies authority NERFINISHED ⓘ |
| expandsAuthorityOf | Food and Drug Administration NERFINISHED ⓘ |
| hasAbbreviation | FDAAA NERFINISHED ⓘ |
| hasCongress | 110 ⓘ |
| hasCountry |
United States of America
ⓘ
surface form:
United States
|
| hasEnactmentDate | 2007-09-27 ⓘ |
| hasPublicLawNumber | P.L. 110-85 NERFINISHED ⓘ |
| hasSectionOn |
active surveillance systems for drug safety
ⓘ
labeling changes for safety reasons ⓘ pediatric device tracking and incentives ⓘ post-market risk management ⓘ |
| hasShortTitle | FDA Amendments Act of 2007 NERFINISHED ⓘ |
| hasStatutesAtLargeCitation | 121 Stat. 823 ⓘ |
| hasTitle | Food and Drug Administration Amendments Act of 2007 NERFINISHED ⓘ |
| hasType | public law ⓘ |
| includes | pediatric research and drug study provisions ⓘ |
| isPartOf | United States food and drug law NERFINISHED ⓘ |
| jurisdiction |
United States of America
ⓘ
surface form:
United States
|
| language | English ⓘ |
| reauthorizes |
Medical Device User Fee and Modernization Act
NERFINISHED
ⓘ
Prescription Drug User Fee Act NERFINISHED ⓘ |
| regulates |
Food and Drug Administration
NERFINISHED
ⓘ
medical devices ⓘ prescription drugs ⓘ |
| requires |
clinical trial registration and results reporting on ClinicalTrials.gov
ⓘ
enhanced post-marketing drug safety studies ⓘ |
| strengthens | FDA post-market safety authorities ⓘ |
| subject |
drug safety
ⓘ
medical device safety ⓘ post-market surveillance ⓘ user fees for drugs and medical devices ⓘ |
| wasEnactedBy | 110th United States Congress NERFINISHED ⓘ |
| wasSignedBy | George W. Bush NERFINISHED ⓘ |
| yearOfEnactment | 2007 ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Public Law 110-85 Description of subject: Public Law 110-85 is a 2007 U.S. federal statute that significantly expanded the Food and Drug Administration’s authority over drug and medical device safety, post-market surveillance, and user fees.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.